Clinical-stage company behind CG-100, a single-use temporary intraluminal device placed in the intestine to keep stool away from a fresh anastomosis and avoid a protective stoma.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.